Lumida
/SION
⌘K
Sionna Therapeutics Inc

Sionna Therapeutics Inc

SION
$7.85USD+3.02%+0.23 today

MARKET CAP

354.9M

P/E (TTM)

FWD P/E

DAY RANGE

$7 – $8

52W RANGE

$4
$55

AI Summary

Stalk
Sell NowMedium

SION has formed a Blow-Off Top and retraced sharply below the 9 and 20 EMAs, testing multi-EMA support and signaling a likely pullback. Medium-term bias is bearish given the unsustainable buying pressure and failed follow-through, while short-term rejection at key EMAs favors immediate execution. The long-term uptrend remains intact above the rising 200 DMA but is currently overshadowed by distribution dynamics.

  • Maintains ~$211M cash and short-term investments funding ops until 2028
  • Intraday stock bounce peaked at +14.9%, reflecting speculative momentum
  • Phase 2a failure of SION-719 undermines core product revenue potential
Full analysis →

Buying

4

institutions

Selling

4

institutions

New Positions

1

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

BUY1.47 M64.88 M+178.90 K+24.9%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

BUY1.49 M64.09 M+25.49 K+19.3%0.00%
CA

Citadel Advisors LLC

Q2 2026

SELL1.16 M50.85 M+-10.89 K+8.7%0.01%
PA

Perceptive Advisors LLC

Q2 2026

SELL905.00 K39.81 M+-411.88 K-24.6%0.60%
CC

Casdin Capital, LLC

Q2 2026

BUYNEW400.00 K17.60 M+400.00 K+0.0%0.88%
MM

Millennium Management LLC

Q2 2026

BUY325.33 K14.31 M+184.69 K+153.8%0.01%
PA

Point72 Asset Management, L.P.

Q2 2026

SELL49.33 K2.17 M+-87.22 K-60.4%0.00%
RC

Rockefeller Capital Management L.P.

Q2 2026

SELL114.005.01 K+-127.00-48.1%0.00%